After sixteen very long years with no truly viable treatment plans for Alzheimer’s, there’s some optimism on the horizon, in a stunning reversal from the formerly-rejected antibody therapy, aducanumab. The most recent research uncovers that large quantities of this medication do, in fact, lessen cognitive decline at the beginning stages of Alzheimer’s. [Read More...] A New Alzheimer’s Medication? Researchers Are Taking a Second Look at This Alzheimer’s Treatment
December 27, 2019
After sixteen very long years with no truly viable treatment plans for Alzheimer’s, there’s some optimism on the horizon, in a stunning reversal from the formerly-rejected antibody therapy, aducanumab. The most recent research uncovers that large quantities of this medication do, in fact, lessen cognitive decline at the beginning stages of Alzheimer’s. [Read More...]